The closing price of Clearside Biomedical Inc (NASDAQ: CLSD) was $1.53 for the day, down -8.38% from the previous closing price of $1.67. In other words, the price has decreased by -$0.1400 from its previous closing price. On the day, 441781 shares were traded.
Ratios:
Our analysis of CLSD’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.42 and its Current Ratio is at 4.42.
On July 29, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.
On May 13, 2020, ROTH Capital started tracking the stock assigning a Buy rating and target price of $8.ROTH Capital initiated its Buy rating on May 13, 2020, with a $8 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 20 ’24 when Chong Ngai Hang Victor bought 30,000 shares for $1.60 per share. The transaction valued at 48,000 led to the insider holds 30,000 shares of the business.
WHITMORE BRADFORD T bought 444,444 shares of CLSD for $599,999 on Feb 07 ’24. The 10% Owner now owns 4,495,034 shares after completing the transaction at $1.35 per share. On Jan 19 ’24, another insider, LASEZKAY GEORGE M, who serves as the CEO of the company, sold 18,000 shares for $1.27 each. As a result, the insider received 22,860 and left with 466,577 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLSD now has a Market Capitalization of 124.78M and an Enterprise Value of 96.88M. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.89. Its current Enterprise Value per Revenue stands at 11.78 whereas that against EBITDA is -4.20.
Stock Price History:
Over the past 52 weeks, CLSD has reached a high of $2.12, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 1.4387, while the 200-Day Moving Average is calculated to be 1.1377.
Shares Statistics:
CLSD traded an average of 351.62K shares per day over the past three months and 495.07k shares per day over the past ten days. A total of 74.72M shares are outstanding, with a floating share count of 63.00M. Insiders hold about 15.69% of the company’s shares, while institutions hold 13.32% stake in the company. Shares short for CLSD as of Mar 15, 2024 were 339.93k with a Short Ratio of 0.97, compared to 161.93k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.45% and a Short% of Float of 0.48%.
Earnings Estimates
The firm’s stock currently is rated by 5 analysts. On average, analysts expect EPS of -$0.14 for the current quarter, with a high estimate of -$0.12 and a low estimate of -$0.16, while EPS last year was -$0.15. The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.12 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.46 and -$0.63 for the fiscal current year, implying an average EPS of -$0.53. EPS for the following year is -$0.56, with 5 analysts recommending between -$0.44 and -$0.66.
